Katherine Blades

Of 760 papers using 35 antibodies that failed knockout-controlled testing in every application, 15.8% showed validation; the other 640 used at least 8,064 animal and 4,424 human tissue samples.

This paper identifies barriers to antibody validation and proposes a consensus-based action plan to improve validation practices across stakeholders.